Stockscreener 앱 받기
228.72
1.78%
-4.14
시장 영업 전:
228.42
-0.30
-0.13%
전일 마감가:
$232.86
열려 있는:
$234
하루 거래량:
5.48M
Relative Volume:
0.84
시가총액:
$404.24B
수익:
$61.16B
순이익/손실:
$4.20B
주가수익비율:
96.62
EPS:
2.3671
순현금흐름:
$19.68B
1주 성능:
+3.54%
1개월 성능:
+6.70%
6개월 성능:
+10.72%
1년 성능:
+16.55%
1일 변동 폭
$226.07
$234.00
1주일 범위
$220.91
$235.25
52주 변동 폭
$164.39
$244.81
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
228.72 | 411.55B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
LLY
Lilly Eli Co
|
1,020.56 | 977.37B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
244.99 | 586.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
AZN
Astrazeneca Plc
|
208.67 | 324.75B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
165.38 | 317.08B | 54.72B | 14.02B | 15.32B | 7.1855 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
The Escalator: HHS, EyePoint Pharmaceuticals, AbbVie and more - Medical Marketing and Media
Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited - Finviz
Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited - Insider Monkey
AbbVie (NYSE:ABBV) Shares Down 1.7%Here's What Happened - MarketBeat
Hot Picks: Microsoft, AbbVie and PNC highlight dividend growth in AI - BNN Bloomberg
Waycross Partners LLC Purchases 8,077 Shares of AbbVie Inc. $ABBV - MarketBeat
First National Bank of Omaha Takes $6.60 Million Position in AbbVie Inc. $ABBV - MarketBeat
Ingalls & Snyder LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is Advisors Capital Management LLC's 5th Largest Position - MarketBeat
Piper Sandler Adjusts Price Target on AbbVie to $299 From $289, Maintains Overweight Rating - marketscreener.com
Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - GlobeNewswire Inc.
The Zacks Analyst Blog AbbVie, RTX, International Business Machines, EVI Industries, and Rocky Mountain Chocolate Factory - Nasdaq
Top Analyst Reports for AbbVie, RTX & IBM - Yahoo Finance Singapore
Assessing AbbVie (ABBV) Valuation After Strong Results And New Rinvoq Vitiligo Filings - Yahoo Finance
AbbVie stock rises as ABBV investors brace for Feb 20 inflation read and Botox pricing fight - Bez Kabli
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell - marketscreener.com
Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell - TradingView
HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating - marketscreener.com
AbbVie Down Since Q4 Earnings Report: How to Play the Stock - Yahoo Finance
AbbVie Inc. $ABBV Shares Bought by NEOS Investment Management LLC - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $219.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Colrain Capital LLC - MarketBeat
Cardano Risk Management B.V. Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Glenview Trust Co Has $95.89 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Arvest Bank Trust Division Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie: Dominating Immunology While Building Oncology Upside (NYSE:ABBV) - Seeking Alpha
AbbVie stock: ABBV heads into Tuesday restart after $231.50 close as Botox pricing fight lingers - Bez Kabli
AbbVie Inc. $ABBV Stake Cut by Zions Bancorporation National Association UT - MarketBeat
AbbVie Inc. $ABBV Shares Sold by M&G PLC - MarketBeat
Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider - GlobeNewswire Inc.
AbbVie Inc. $ABBV Position Boosted by Southeast Asset Advisors LLC - MarketBeat
Mmbg Investment Advisors CO. Has $3.96 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Vanguard Group Inc. Acquires 448,554 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Yahoo Finance
AbbVie Inc. $ABBV Shares Purchased by Capital Planning Advisors LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Where is AbbVie Inc. (ABBV) headed according to the Street? - MSN
1 No-Brainer Dividend Stock to Buy on the Dip - The Globe and Mail
AbbVie stock ends higher Friday; what traders watch for ABBV after the Presidents Day break - TechStock²
AbbVie Inc. $ABBV Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
Shell Asset Management Co. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
PNC Financial Services Group Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV - MarketBeat
HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV - MarketBeat
Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
ABN Amro Investment Solutions Has $14.53 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Aberdeen Group plc Sells 67,321 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie’s Botox Lawsuit Puts Medicare Pricing Risks In Focus - Yahoo Finance
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
0.07%
자본화:
|
볼륨(24시간):